Objective: Studies of vasomotor symptoms (VMS) typically measure VMS via daily diaries completed at the end of the day. VMS can also be measured via diaries completed throughout the day or via physiological monitorsVmodalities with lower recall demands. We examined the degree of correspondence between three VMS measurement modalities: retrospective end-of-day/morning diaries, prospective reporting, and physiological monitoring. We determined whether discrepancies between measurement modalities varied by participant characteristics.
V asomotor symptoms (VMS), such as hot flashes and night sweats, affect approximately 70% of American women transitioning through menopause 1 and are a leading concern for women during this time. For example, women cite VMS as the menopausal symptom most commonly discussed with their healthcare professionals, 2 and women with VMS consult doctors more often than women without these symptoms. 3 Therefore, VMS are an important health issue for midlife women.
The reluctance of many women to take postmenopausal hormone therapy since the publication of the Women's Health Initiative findings 4, 5 has led to a recent search for new nonhormonal treatments for VMS and associated clinical trials. In these trials, daily diaries are considered the gold standard measure of VMS. 6 In many of these diaries, women are asked to recall at the end of the day their VMS experienced during the previous day and, upon waking, their VMS experienced during the night. 7<10 Other methodologies ask women to recall their VMS during the prior 24 hours, summing those experienced during the day and during the night. In contrast to a prospective report in which women record a VMS event as they are experiencing it, these diaries are retrospective in that they ask women to recall their VMS during a given period. It is not known how well these retrospective reports correspond with prospective VMS reports or physiologically assessed VMS. 11 One key factor affecting VMS reporting is negative affect, which influences the memory for other physical symptoms. 12 In fact, anxiety is the strongest and most consistent factor associated with the reporting of VMS. 1,13<16 Although the relationship between anxiety and VMS may be multifactorial, 17 higher baseline anxiety was significantly and independently associated with more VMS reporting in the Study of Women's Health Across the Nation (SWAN). 1 Moreover, SWAN women with elevated negative affect reported being more bothered by their VMS even after controlling for the frequency at which VMS were reported to occur. 18 One study found that reported VMS lacking physiological evidence were most common among women with elevated negative affect. 19 The primary aim of the current study is to compare VMS estimates from daily diaries to prospectively reported or physiologically recorded VMS during waking and sleeping hours across 4 days and nights. Next, we examine the role of negative affect in the degree of similarity or difference between these measurement modalities. Given anxiety's established association with VMS reporting, 1, 15 we hypothesize that, compared with women with low levels of anxiety, women with higher anxiety symptoms would (1) recall more daytime VMS at the end of the day than were prospectively reported or physiologically detected during the day and (2) recall more overnight VMS upon waking the next morning than were reported or physiologically detected during the prior night. In an exploratory fashion, we investigate whether discrepancies between VMS estimates via these measurement modalities vary by race/ ethnicity and sleep given the importance of these factors to VMS and their reporting. 1, 15, 18, 20, 21 
METHODS

Study population
SWAN is a multisite, multiethnic, longitudinal study that aims to characterize biological and psychosocial changes during the menopausal transition. 22 At their 10th annual visit for SWAN, a subset of women (25 African-American women and 27 white women) from the Pittsburgh site was invited to participate in SWAN FLASHES, an ancillary study including physiological measurement of VMS, methods for which have been described previously. 20, 23 Briefly, the inclusion criteria for SWAN FLASHES included having intact uterus and ovaries, currently experiencing VMS (in the past 2 wk), and not being pregnant. Use of oral contraceptives, hormone therapy, selective serotonin reuptake inhibitor/serotonin-noradrenaline reuptake inhibitor antidepressants, or chemotherapy for breast cancer was exclusionary. Participants were recruited such that approximately equal numbers of African-American and white women were represented in each obesity category (lean, G25 kg/m 2 ; overweight, 25-29 kg/m 2 ; obese, Q30.0 kg/m 2 ).
Design and procedures
Women were assessed for height and weight, given questionnaires (ie, demographics, medical history, and psychological measures), and equipped with a daily diary to be completed before bed and upon waking the next morning, an electronic diary to be completed throughout the day, a physiological hot flash monitor, and a wrist actigraph for four 24-hour ambulatory assessment periods. Procedures were approved by the University of Pittsburgh institutional review board, and all participants provided a written informed consent form.
End-of-day-recalled and morning-recalled VMS Before falling asleep each night, participants were asked to report the number of VMS they experienced during that day in their end-of-day diary. In addition, upon waking each morning, participants were asked to report the number of VMS they experienced during the prior night in their morning diary.
Prospectively reported VMS
Throughout the day, participants were asked to report their VMS at the time of occurrence. They reported these VMS events in three ways: (1) completed an entry in the portable electronic diary (Palm Z22; Palm Inc, Sunnyvale, CA); (2) pressed event mark buttons on the physiological hot flash monitor (3991/2-SCL Single-Channel Hot Flash Monitor BioLog; UFI, Morro Bay, CA), and (3) pressed a button on the wrist actigraph (Minimitter Actiwatch-64; Respironics Inc, Murrysville, PA). A report of VMS on any of these three devices was considered a prospective report of VMS.
Physiologically detected VMS
VMS were measured physiologically via sternal skin conductance using the BioLog hot flash monitor, 11,24 a portable device worn around the waist that continuously measures sternal skin conductance in the ambulatory setting. Skin conductance was sampled at 1 Hz from the sternum via a 0.5-V constantvoltage circuit passed between two silver/silver chloride electrodes (UFI) filled with 0.05 M KCl Velvachol/glycol paste. 25 Using the UFI software (DPS version 3.6), all skin conductance rises meeting the criterion of 2-Kmho in 30 seconds were flagged for inspection. Those showing the characteristic VMS pattern were coded as a VMS event. Submaximal rises were also considered, and those events showing the characteristic VMS pattern were also coded as events. This procedure has been shown to be reliable. 26, 27 A 20-minute lockout period, during which no further events were coded, was implemented after the start of each VMS event.
Psychological questionnaires
Anxiety symptoms were evaluated with the Spielberger State-Trait Anxiety Inventory, a well-validated scale that measures state and trait anxiety 28 ; depressive symptoms were evaluated with the widely used and well-validated Center for Epidemiologic Studies Depression Scale 29 ; and perceived stress was evaluate with the widely used Cohen Perceived Stress Scale, which queries about one's general appraisal of stress. 30 
Sleep characteristics
Sleep characteristics were measured by both diary report and actigraphy. In their morning diary completed upon waking each morning, participants reported the number of awakenings and total minutes of awakening during the prior night, as well as how that night of sleep compared with a usual night for them (5-point scale ranging from much worse [0] to much better [4] ). Self-reported bedtime and rise time were entered for calculations of sleep-wake variables. Actigraphic sleep was measured via a wrist actigraph (Actiwatch-64) worn throughout the ambulatory monitoring period. Actigraphy data were collected in 1-minute epochs and analyzed using the software program Actiware version 5.04. 20 Each awakening was defined as a total activity count greater than a sensitivity threshold of 40. Wakefulness after sleep onset (WASO; total minutes of wakefulness between sleep onset and final wake time) was determined via actigraphy and considered here as the main sleep characteristic given the previously documented associations between reported VMS and wakening during the night. 20, 21 Covariates
Demographics, medical history, medication use, menstrual history, and health behaviors were assessed by questionnaires administered during the SWAN FLASHES visit. Race/ethnicity was determined in response to the question, BHow would you describe your primary racial or ethnic group?[ Education status was determined from self-reported highest grade completed and separated into three categories: high school, some college or vocational school, and college or higher. Menopause status was determined from reported bleeding patterns (perimenopause status was defined as bleeding in the previous 3 mo with a decrease in cycle predictability in the past year or more than 3 mo but less than 12 mo of amenorrhea; postmenopause status was defined as more than 12 mo of amenorrhea). Alcohol use and tobacco use were determined by the current reported number of drinks per day/week/month and cigarettes per day, respectively. Body mass index (BMI) was calculated from height (measured with a fixed stadiometer; Seca, Hanover, MD) and weight (measured with a calibrated balance beam scale; Healthometer, Alsip, IL).
Statistical analysis
We calculated the number of VMS that were retrospectively reported in daily diaries, prospectively reported, and physiologically measured during daytime and overnight. For each participant, the number of recalled daytime VMS from the end-of-day diary was compared with the number of prospectively reported or physiologically measured VMS that occurred throughout that same day. Similarly, the number of recalled overnight VMS from the morning diary was compared with the number of prospectively reported or physiologically measured VMS that occurred overnight. Difference scores (number of VMS) between these measurement modalities were calculated: (1) end-of-day/ morning-recalled, prospectively reported VMS and (2) end-ofday/morning-recalled, physiologically measured VMS.
Because VMS data were collected for multiple days/nights per woman (usually four), generalized estimating equations were used to examine associations between outcomes, covariates, and predictors. State and trait anxiety, depressive symptoms, perceived stress, and WASO were considered in relation to each difference score in separate models. State anxiety, trait anxiety, and depressive symptoms were natural logY transformed for analysis. Covariates were selected based on their association with the outcome at P G 0.15, with age, race/ ethnicity, postmenopause status, and BMI included in the final models. We tested interactions between race/ethnicity and psychosocial or sleep characteristics with cross-product terms; where interactions were significant, stratified models were presented. All tests were two-tailed, with an > of 0.05. Analyses were performed with SAS version 9.3 (SAS Institute, Cary, NC).
RESULTS
Participants were, on average, 58 years old and postmenopausal (Table 1) . Compared with white women, African-American women had higher BMI, reported more VMS prospectively, and experienced more physiological VMS.
At the end of the day, women underestimated the number of daytime VMS as compared with those that were prospectively reported or physiologically recorded throughout the day ( Table 2 ). This tendency varied by race/ethnicity, with African-American women being more likely to recall fewer VMS than were prospectively reported or physiologically detected relative to white women. For nighttime VMS, on average, women slightly overestimated the number of VMS upon waking than were prospective reported or detected on physiological monitoring.
Daytime VMS reporting differences
In multivariable models adjusted for age, race/ethnicity, menopause status, and BMI, higher trait anxiety was associated with greater underestimation of VMS at the end of the day than those that were prospectively reported or physiologically measured throughout the day (Table 3) . A similar but slightly weaker pattern was apparent for depressive symp-toms and perceived stress (perceived stress: b [SE] = j0.11 [0.07], P = 0.08). Considering the covariates in these models, neither BMI nor age was associated with these VMS reporting differences (P's 9 0. We observed some indications of differences by race/ ethnicity in relations between negative affect and the discrepancies between the number of VMS recalled at the end of the day and the number of VMS prospectively reported throughout the day (interactions with race: state anxiety, P = 0.07; trait anxiety, P = 0.09; depressive symptoms, P = 0.03), as well as the difference between the number of VMS recalled at the end of the day and those that were physiologically measured throughout the day (interaction for race and depressive symptoms: P = 0.08) in multivariable models adjusted for age, race/ethnicity, menopause status, and BMI. For example, the greater underestimation of VMS at the end of the day versus those prospectively reported with elevated negative affect was apparent only among African-American women (state anxiety: 
Nighttime VMS reporting differences during sleeping hours
With respect to nighttime VMS, higher WASO was associated with greater overestimation of overnight VMS in the morning diary as compared with VMS physiologically detected during the night (Table 4 ). Notably, no affective factors were associated with nighttime VMS reporting differences (P's 9 0.10), nor were any of the covariates (BMI, age, and menopause status) associated with nighttime VMS reporting differences (P's 9 0.10).
Suggestion of effect modification by race/ethnicity (P = 0.09) was noted for the relation between WASO and the difference between morning-recalled and overnight-reported VMS in multivariable models adjusted for age, race/ethnicity, menopause status, and BMI. For example, the tendency with worse sleep to overestimate VMS in the morning as compared with the number of VMS prospectively reported or physiologically measured was apparent only among white women (vs prospective report: b [SE] = 0.02 [0.01], P = 0.02; vs physiological monitor: b [SE] = 0.04 [0.01], P = 0.002), but not among African-American women (P's 9 0.05).
DISCUSSION
The primary aim of this study was to examine the accuracy of end-of-day and morning VMS recall by comparing them with prospective report and physiological detection of VMS.
We found that the women in this study had a tendency to underestimate the number of VMS at the end of the day compared with those prospectively reported or physiologically measured throughout the day. The tendency to underestimate daytime VMS was especially pronounced among African-American women and, contrary to our expectations, more anxious women. For overnight VMS, women overestimated the number of overnight VMS upon waking as compared with those prospectively reported or physiologically detected during the night. This pattern was particularly pronounced among women with poorer sleep (more wakefulness during the night). Racial/ethnic differences pointed to a pattern of African-American women being most likely to underestimate VMS and a pattern of white women being most likely to overestimate VMS, particularly in the context of negative affect or poor sleep.
This study is one of the few studies to investigate the degree of correspondence between VMS assessed through retrospective recall, prospective report, and physiological detection. This study is important given that findings in studies using VMS diaries completed prospectively or retrospectively are often treated interchangeably. However, daytime VMS may be systematically underestimated, and overnight VMS may be systematically overestimated. Moreover, recalled VMS are subject to the additional influence of affect and sleep. These findings underscore the potential importance of using prospective VMS reports.
Other symptom literatures, such as those related to pain, have previously described individuals' difficulty in precisely recalling these symptoms. Notably, research in the pain literature shows greater accuracy for recall of novel acute pain than for recall of chronic or repeated episodic pain, 12, 31 such as the VMS experienced here. Memory for pain is also influenced by the mood at the time of recall. 12, 32 For example, negative affect, particularly anxiety, impacts both symptom reporting and memory for pain across a range of physical conditions. 33<35 For VMS, anxiety plays an important role in VMS reporting. 14<16 However, negative affect is typically associated with overestimation of symptoms. 36 Why anxiety was related to underestimation of VMS in our study is not entirely clear. A possible theory is that anxiety plays differential roles in prospective and retrospective symptom reporting, as some research shows that anxiety is associated with elevated prospective symptom reports, but not symptom recall. 37 It is also notable that the greater underestimation associated with higher negative affect was most apparent among African-American women. Prior work has not considered that the relation between affect and VMS reporting may vary by race; our findings suggest the potential importance of considering racial/ethnic differences.
Overestimation of nighttime VMS upon waking compared with those prospectively reported or physiologically measured during the night is in accordance with our previous work showing moderate to no correlation between prospectively reported or physiological VMS and morning-diary-recalled VMS, respectively. 20 Consistent with links between poor sleep and VMS, 18, 20 women overestimated VMS upon waking if they had poorer sleep (ie, more sleep disruptions). Measuing nighttime VMS via self-report is a challenge, given that women are typically sleeping; thereby, physiological monitoring can be useful in obtaining overnight VMS estimates. However, physiological monitoring is often not feasible for large studies; thus, the accuracy of morning reports becomes paramount. Consistent with our prior work, 20 the present findings indicate that these morning reports may be somewhat inflated if a woman has had a poor night of sleep.
Consistent with previous reports, 1,15,16,38<40 African-American women prospectively reported more VMS and experienced more physiological VMS than white women. Greater underestimation of daytime VMS at the end of the day versus prospective measures was also more apparent among African-American women. The reason for this racial/ethnic difference is not entirely clear and should be interpreted with caution, given the small numbers of women in these stratified models. We considered whether the racial/ethnic differences in BMI might have played a role, but BMI was adjusted for in all models and was generally not associated with the reporting difference scores. Other demographic factors (eg, age, employment status, marital status, living arrangements) were also considered but were not related to VMS reporting outcomes, nor did they account for these racial/ethnic differences (data not shown). Other works show variations by race/ethnicity in both VMS 19 and pain reporting. 25,41<44 The present findings highlight the potential importance of considering racial/ethnic differences in patterns of VMS reporting.
Several limitations of this study should be mentioned. The small size of our sample may have limited the power to detect associations, especially for interactions and stratified models. Interpretation of racial/ethnic differences, in particular, requires caution. Moreover, given the inclusion of only African-American and white women, we cannot draw conclusions about other racial/ethnic groups.
This study has numerous strengths. This is the first study to examine the concordance/discordance of three different VMS measurement modalities: retrospective daily diary, prospective report, and physiological detection. We compared both subjective versus objective measures of VMS and retrospective versus prospective assessments of VMS. This study also evaluated daily diaries similar to those used in recent studies of VMS treatments. 6<10 In addition, as mentioned above, we provided three different ways to prospectively report VMS events and monitored women in the home setting. Finally, this study included a well-characterized sample of African-American and white women in approximately equal numbers.
CONCLUSIONS
This work highlights that different measurement modalities yield different VMS estimates. In particular, women underestimated the number of VMS at the end of the day compared with those prospectively reported or physiologically detected throughout the day. Women overestimated the number of VMS that they experienced during the night upon waking, particularly when they had poorer sleep. These findings have implications for understanding the results of VMS treatment studies, which largely rely on retrospectively recalled VMS. These retrospective reports may capture not only VMS but also aspects of sleep and mood. These findings underscore the potential importance of prospective VMS measures for research requiring precise VMS estimates.
